vTv Therapeutics CEO Stephen Holcombe's 2018 pay falls 63% to $459.4K

vTv Therapeutics reports 2018 executive compensation

Published: March 15, 2019

vTv Therapeutics reported fiscal year 2018 executive compensation information on March 15, 2019.

In 2018, four executives at vTv Therapeutics received on average a compensation package of $370K, a 58% decrease compared to previous year.

Average pay of disclosed executives at vTv Therapeutics

Stephen L. Holcombe, Chief Executive Officer, received $459.4K in total, which decreased by 63% compared to 2017. 97.95% of Holcombe's compensation, or $450K, was in salary. Holcombe also received $9.4K in other compensation.

Larry D. Altstiel, Chief Medical Officer, received a compensation package of $413.4K, which decreased by 58% compared to previous year. 96.77% of the compensation package, or $400K, was in salary.

Rudy C. Howard, Chief Financial Officer, earned $357.2K in 2018, a 58% decrease compared to previous year.

Jeffrey B. Kindler, Chairman, received $250K in 2018, which decreases by 45% compared to 2017.